ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2 - Diagnostic Criteria and Appropriate Utilization

Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H. Falk; Victor A. Ferrari; Marianna Fontana; Olivier Gheysens; Julian D. Gillmore; Andor W.J.M. Glaudemans; Mazen A. Hanna; Bouke P.C. Hazenberg; Arnt V. Kristen; Raymond Y. Kwong; Mathew S. Maurer; Giampaolo Merlini; Edward J. Miller; James C. Moon; Venkatesh L. Murthy; C. Cristina Quarta; Claudio Rapezzi; Frederick L. Ruberg; Sanjiv J. Shah; Riemer H.J.A. Slart; Hein J. Verberne; Jamieson M. Bourque

doi:10.1161/HCI.0000000000000030

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2 - Diagnostic Criteria and Appropriate Utilization

Sharmila Dorbala, Yukio Ando, Sabahat Bokhari, Angela Dispenzieri, Rodney H. Falk, Victor A. Ferrari, Marianna Fontana, Olivier Gheysens, Julian D. Gillmore, Andor W.J.M. Glaudemans, Mazen A. Hanna, Bouke P.C. Hazenberg, Arnt V. Kristen, Raymond Y. Kwong, Mathew S. Maurer, Giampaolo Merlini, Edward J. Miller, James C. Moon, Venkatesh L. Murthy, C. Cristina QuartaClaudio Rapezzi, Frederick L. Ruberg, Sanjiv J. Shah, Riemer H.J.A. Slart, Hein J. Verberne, Jamieson M. Bourque

Hematology

Research output: Contribution to journal › Review article › peer-review

Abstract

Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

Original language	English (US)
Pages (from-to)	E000030
Journal	Circulation: Cardiovascular Imaging
Volume	14
Issue number	7
DOIs	https://doi.org/10.1161/HCI.0000000000000030
State	Published - Jul 1 2021

Keywords

AHA Scientific Statements
appropriate use
cardiac amyloidosis
diagnosis
expert consensus
multimodality

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1161/HCI.0000000000000030

Cite this

Dorbala, S., Ando, Y., Bokhari, S., Dispenzieri, A., Falk, R. H., Ferrari, V. A., Fontana, M., Gheysens, O., Gillmore, J. D., Glaudemans, A. W. J. M., Hanna, M. A., Hazenberg, B. P. C., Kristen, A. V., Kwong, R. Y., Maurer, M. S., Merlini, G., Miller, E. J., Moon, J. C., Murthy, V. L., ... Bourque, J. M. (2021). ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2 - Diagnostic Criteria and Appropriate Utilization. Circulation: Cardiovascular Imaging, 14(7), E000030. https://doi.org/10.1161/HCI.0000000000000030

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2 - Diagnostic Criteria and Appropriate Utilization. / Dorbala, Sharmila; Ando, Yukio; Bokhari, Sabahat et al.
In: Circulation: Cardiovascular Imaging, Vol. 14, No. 7, 01.07.2021, p. E000030.

Research output: Contribution to journal › Review article › peer-review

Dorbala, S, Ando, Y, Bokhari, S, Dispenzieri, A, Falk, RH, Ferrari, VA, Fontana, M, Gheysens, O, Gillmore, JD, Glaudemans, AWJM, Hanna, MA, Hazenberg, BPC, Kristen, AV, Kwong, RY, Maurer, MS, Merlini, G, Miller, EJ, Moon, JC, Murthy, VL, Quarta, CC, Rapezzi, C, Ruberg, FL, Shah, SJ, Slart, RHJA, Verberne, HJ & Bourque, JM 2021, 'ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2 - Diagnostic Criteria and Appropriate Utilization', Circulation: Cardiovascular Imaging, vol. 14, no. 7, pp. E000030. https://doi.org/10.1161/HCI.0000000000000030

@article{419de9badfc24690877afe61615c0dd8,

title = "ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2 - Diagnostic Criteria and Appropriate Utilization",

abstract = "Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.",

keywords = "AHA Scientific Statements, appropriate use, cardiac amyloidosis, diagnosis, expert consensus, multimodality",

author = "Sharmila Dorbala and Yukio Ando and Sabahat Bokhari and Angela Dispenzieri and Falk, {Rodney H.} and Ferrari, {Victor A.} and Marianna Fontana and Olivier Gheysens and Gillmore, {Julian D.} and Glaudemans, {Andor W.J.M.} and Hanna, {Mazen A.} and Hazenberg, {Bouke P.C.} and Kristen, {Arnt V.} and Kwong, {Raymond Y.} and Maurer, {Mathew S.} and Giampaolo Merlini and Miller, {Edward J.} and Moon, {James C.} and Murthy, {Venkatesh L.} and Quarta, {C. Cristina} and Claudio Rapezzi and Ruberg, {Frederick L.} and Shah, {Sanjiv J.} and Slart, {Riemer H.J.A.} and Verberne, {Hein J.} and Bourque, {Jamieson M.}",

year = "2021",

month = jul,

day = "1",

doi = "10.1161/HCI.0000000000000030",

language = "English (US)",

volume = "14",

pages = "E000030",

journal = "Circulation: Cardiovascular Imaging",

issn = "1941-9651",

publisher = "Lippincott Williams and Wilkins",

number = "7",

}

TY - JOUR

T1 - ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis

T2 - Part 2 of 2 - Diagnostic Criteria and Appropriate Utilization

AU - Dorbala, Sharmila

AU - Ando, Yukio

AU - Bokhari, Sabahat

AU - Dispenzieri, Angela

AU - Falk, Rodney H.

AU - Ferrari, Victor A.

AU - Fontana, Marianna

AU - Gheysens, Olivier

AU - Gillmore, Julian D.

AU - Glaudemans, Andor W.J.M.

AU - Hanna, Mazen A.

AU - Hazenberg, Bouke P.C.

AU - Kristen, Arnt V.

AU - Kwong, Raymond Y.

AU - Maurer, Mathew S.

AU - Merlini, Giampaolo

AU - Miller, Edward J.

AU - Moon, James C.

AU - Murthy, Venkatesh L.

AU - Quarta, C. Cristina

AU - Rapezzi, Claudio

AU - Ruberg, Frederick L.

AU - Shah, Sanjiv J.

AU - Slart, Riemer H.J.A.

AU - Verberne, Hein J.

AU - Bourque, Jamieson M.

PY - 2021/7/1

Y1 - 2021/7/1

N2 - Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

AB - Cardiac amyloidosis is emerging as an underdiagnosed cause of heart failure and mortality. Growing literature suggests that a noninvasive diagnosis of cardiac amyloidosis is now feasible. However, the diagnostic criteria and utilization of imaging in cardiac amyloidosis are not standardized. In this paper, Part 2 of a series, a panel of international experts from multiple societies define the diagnostic criteria for cardiac amyloidosis and appropriate utilization of echocardiography, cardiovascular magnetic resonance imaging, and radionuclide imaging in the evaluation of patients with known or suspected cardiac amyloidosis.

KW - AHA Scientific Statements

KW - appropriate use

KW - cardiac amyloidosis

KW - diagnosis

KW - expert consensus

KW - multimodality

UR - http://www.scopus.com/inward/record.url?scp=85111117183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85111117183&partnerID=8YFLogxK

U2 - 10.1161/HCI.0000000000000030

DO - 10.1161/HCI.0000000000000030

M3 - Review article

C2 - 34196222

AN - SCOPUS:85111117183

SN - 1941-9651

VL - 14

SP - E000030

JO - Circulation: Cardiovascular Imaging

JF - Circulation: Cardiovascular Imaging

IS - 7

ER -

ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2 - Diagnostic Criteria and Appropriate Utilization

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this